Diagnosis and Management of Iron Deficiency Anemia
Based on the laboratory results provided, this patient has iron deficiency anemia requiring oral iron supplementation. The ferritin level of 92 μg/L with normal transferrin saturation (0.33) in the absence of clear inflammatory markers suggests iron deficiency, particularly in the context of anemia.
Interpretation of Laboratory Results
Iron Studies Analysis:
- Iron: 24.2 μmol/L (normal range: 10.6-33.8 μmol/L) - Within normal limits
- Transferrin: 2.94 g/L (normal range: 2.00-4.00 g/L) - Within normal limits
- Transferrin Saturation: 0.33 (normal range: 0.13-0.50) - Within normal limits
- TIBC: 74 μmol/L (normal range: 50-100 μmol/L) - Within normal limits
- Vitamin B12: 405 pmol/L (>220 pmol/L: Normal) - No B12 deficiency
- Ferritin: 92 μg/L - Borderline low
Diagnostic Reasoning:
- According to European guidelines, ferritin levels <30 μg/L in the absence of inflammation definitively indicate iron deficiency 1
- However, in the presence of inflammation, ferritin up to 100 μg/L may still be consistent with iron deficiency 1
- The ferritin level of 92 μg/L falls into this borderline category, suggesting possible iron deficiency, especially if there is any underlying inflammatory condition
Diagnostic Algorithm
Assess for underlying inflammation:
- Check CRP and ESR (not provided in the lab results)
- If inflammation present: ferritin <100 μg/L indicates iron deficiency
- If no inflammation: ferritin <30 μg/L indicates iron deficiency
Evaluate red blood cell indices (not provided in the results):
- MCV (Mean Corpuscular Volume) - typically low in iron deficiency
- RDW (Red Cell Distribution Width) - typically elevated in iron deficiency
Consider mixed deficiency states:
- Vitamin B12 deficiency has been ruled out (level 405 pmol/L)
- Folate status should be checked (not provided)
Management Plan
Iron supplementation:
- Oral iron therapy is the first-line treatment for iron deficiency anemia 1
- Recommended dosage: 100-200 mg elemental iron daily in divided doses
- Common formulations: ferrous sulfate (65 mg elemental iron per 325 mg tablet), ferrous gluconate, or ferrous fumarate
Follow-up monitoring:
- Check hemoglobin after 2-4 weeks to confirm response
- Continue iron therapy for 3-6 months after normalization of hemoglobin to replenish iron stores
- Monitor ferritin levels until >100 μg/L
Investigate underlying cause:
- Evaluate for sources of blood loss (menstrual, gastrointestinal)
- Consider endoscopic evaluation if no obvious source identified
- Screen for celiac disease or other malabsorption disorders
Important Clinical Considerations
Pitfall to avoid: Relying solely on normal transferrin saturation to rule out iron deficiency. In early iron deficiency or mixed anemia states, transferrin saturation may still be normal while ferritin is low 1
Caution: Normal serum iron does not exclude iron deficiency as it fluctuates throughout the day and with meals
Key point: In patients with potential inflammatory conditions (such as IBD), ferritin levels up to 100 μg/L may still represent iron deficiency 1
Treatment response: Hemoglobin should increase by approximately 1-2 g/dL within 2-4 weeks of starting iron therapy if iron deficiency is the correct diagnosis
If there is no response to oral iron therapy after 4 weeks, consider parenteral iron administration or further investigation for other causes of anemia or concomitant conditions affecting iron metabolism.